Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-65 y. old, non or ex-smokers for \> 6 months~* Mild to moderate asthmatic in general good health~* On either low-dose inhaled corticosteroid or steroid naive~* No other asthma medication~* Regular sputum producer~* EOS more than 3% at randomization,~* FEV1 \> 70%~Exclusion Criteria:~* Respiratory infection within last 4 weeks~* Any condition that may affect the conduct of the study as per the investigators

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- TPI ASM8 (Type: EXPERIMENTAL): ASM8 0.25mg
- ASM8 as TPI ASM8 (Type: EXPERIMENTAL): TPI ASM8 0.5mg

Based on this trial design, predict the completion outcome and termination type (if applicable).